학술논문


EBSCO Discovery Service
발행년
-
(예 : 2010-2015)
전자자료 공정이용 안내

우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.

공정이용 지침
  • 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
  • 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
  • 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
  • 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
  • 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
  • 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
  • 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
  • 상업적·영리적 목적으로 자료를 전송·복제·활용
  • ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
  • EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
  • 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
  • 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
  • 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문' 에서 검색결과 708건 | 목록 1~20
Academic Journal
Radom M; UMR 9019 CNRS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Buffet C; Sorbonne Université, Service de Pathologies Thyroïdiennes et Tumeurs endocrines, Groupe de Recherche Clinique n°16 Tumeurs Thyroïdiennes, AP-HP, Hôpital Pitié-Salpêtrière, Paris, France.; Cazarin J; UMR 9019 CNRS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Instituto de Biofísica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, 21941-170, RJ, Brazil.; Harinquet M; UMR 9019 CNRS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; de Faria CC; UMR 9019 CNRS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Brayé F; INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Nobre C; INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Aglave M; Bioinformatics Plateform, Gustave Roussy, Villejuif, France.; Mesloub Y; Bioinformatics Plateform, Gustave Roussy, Villejuif, France.; Dayris T; Bioinformatics Plateform, Gustave Roussy, Villejuif, France.; Droin N; AMMICa Platform, INSERM US23, CNRS UAR 3655, Gustave Roussy, Villejuif, France.; Godefroy K; Cancer Medical Pathology and Biology Department, Gustave Roussy, Villejuif, France.; Bani MA; Cancer Medical Pathology and Biology Department, Gustave Roussy, Villejuif, France.; Ghuzlan AA; UMR 9019 CNRS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Cancer Medical Pathology and Biology Department, Gustave Roussy, Villejuif, France.; Leboulleux S; Department of Endocrinology and Diabetology, Hôpitaux Universitaires de Genève, Geneve, Switzerland.; Lamartina L; Cancer Medicine Department, Gustave Roussy, Université Paris Saclay, Villejuif, France.; Dupuy C; UMR 9019 CNRS, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publisher: Ivyspring International Country of Publication: Australia NLM ID: 101235568 Publication Model: eCollection Cited Medium: Internet ISSN: 1449-2288 (Electronic) Linking ISSN: 14492288 NLM ISO Abbreviation: Int J Biol Sci Subsets: MEDLINE
Academic Journal
Carr RM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Vorobyev D; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Lasho T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Marks DL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Tolosa EJ; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Vedder A; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Tampa, FL, USA.; Almada LL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Yurcheko A; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Padioleau I; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France.; Alver B; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, MN, USA.; Coltro G; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Binder M; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Safgren SL; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Horn I; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; You X; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.; Solary E; INSERM U1170 and Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.; Balasis ME; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Tampa, FL, USA.; Berger K; London Regional Transgenic and Gene Targeting Facility, Lawson Health Research Institute University of Western Ontario, London, ON, Canada.; Hiebert J; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Witzig T; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Buradkar A; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Graf T; 5TH Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Valent P; 5TH Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Ludwig Boltzmann Institute for Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.; Mangaonkar AA; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Robertson KD; Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, MN, USA.; Howard MT; Department of Laboratory Medicine and Pathology, Mayo Clinic, MN, USA.; Kaufmann SH; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA.; Pin C; London Regional Transgenic and Gene Targeting Facility, Lawson Health Research Institute University of Western Ontario, London, ON, Canada.; Fernandez-Zapico ME; Schulze Center for Novel Therapeutics, Division of Oncology Research, Mayo Clinic, MN, USA.; Geissler K; Sigmund Freud University Vienna, Vienna, Austria.; Droin N; INSERM U1170 and Department of Hematology, Gustave Roussy Cancer Center, Villejuif, France.; Padron E; Chemical Biology and Molecular Medicine Program, Moffitt Cancer Center, Tampa, FL, USA.; Zhang J; McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, WI, USA.; Nikolaev S; INSERM U981, Gustave Roussy Cancer Center, Villejuif, France. sergey.nikolaev@gustaveroussy.fr.; Patnaik MM; Division of Hematology, Department of Internal Medicine, Mayo Clinic, MN, USA. patnaik.mrinal@mayo.edu.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Hidaoui D; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Porquet A; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Chelbi R; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Inovarion, 75005, Paris, France.; Bohm M; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Inovarion, 75005, Paris, France.; Polyzou A; IRCAN Institute for Research on Cancer and Aging, INSERM U1081, CNRS UMR 7284, Université Côte d'Azur, Nice, France.; Alcazer V; Centre International de Recherche en Infectiologie, INSERM U1111 CNRS UMR530, Lyon, France.; Service d'hématologie Clinique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France.; Depil S; Centre de Recherche en Cancérologie de Lyon, UMR INSERM U1052 CNRS 5286 Université Claude Bernard Lyon 1, Centre Léon Bérard, Lyon, France.; Imanci A; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Morabito M; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Renneville A; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; INSERM US23, CNRS UMS 3655, Gustave Roussy Cancer Center, Villejuif, France.; Selimoglu-Buet D; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Thépot S; Clinical Hematology Department, University Hospital, Angers, France.; Itzykson R; Université Paris Cité, Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, F-75010, Paris, France.; Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, F-75010, Paris, France.; Laplane L; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Institut d'Histoire et Philosophie des Sciences et des Techniques, Université Paris I Panthéon-Sorbonne, Paris, France.; Droin N; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; INSERM US23, CNRS UMS 3655, Gustave Roussy Cancer Center, Villejuif, France.; Trompouki E; IRCAN Institute for Research on Cancer and Aging, INSERM U1081, CNRS UMR 7284, Université Côte d'Azur, Nice, France.; Elvira-Matelot E; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Solary E; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France.; Clinical Hematology Department, Gustave Roussy Cancer Center, Villejuif, France.; Porteu F; INSERM UMR1287, Gustave Roussy Cancer Center, Université Paris-Saclay, 94805, Villejuif, France. francoise.porteu@gustaveroussy.fr.
Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
Academic Journal
Boutin J; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Fayet S; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; Marin V; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Bergès C; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; CHU de Bordeaux, Medical Genetic Laboratory, Bordeaux, France.; Riandière M; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; Toutain J; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; CHU de Bordeaux, Medical Genetic Laboratory, Bordeaux, France.; Lamrissi-Garcia I; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; Thibault C; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; Cappellen D; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; CHU de Bordeaux, Tumor Biology and Tumor Bank Laboratory, Bordeaux, France.; Dabernat S; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; CHU de Bordeaux, Biochemistry Laboratory, Bordeaux, France.; Poulet A; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France.; Francillette M; INSERM US23, CNRS UAR 3655, AMMICa, Genomic Platform, Gustave Roussy Cancer Center, Villejuif, France.; Droin N; INSERM US23, CNRS UAR 3655, AMMICa, Genomic Platform, Gustave Roussy Cancer Center, Villejuif, France.; INSERM U1287, Gustave Roussy Cancer Center, Villejuif, France.; Debeissat C; Etablissement Français du Sang Nouvelle Aquitaine, Place Amélie Raba Léon, Bordeaux, France.; Univ Bordeaux, Inserm Bordeaux UMR 1211 Rare Diseases, Genetics and Metabolism, Bordeaux, France.; Brunet de la Grange P; Etablissement Français du Sang Nouvelle Aquitaine, Place Amélie Raba Léon, Bordeaux, France.; Univ Bordeaux, Inserm Bordeaux UMR 1211 Rare Diseases, Genetics and Metabolism, Bordeaux, France.; Moreau-Gaudry F; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; CHU de Bordeaux, Biochemistry Laboratory, Bordeaux, France. francois.moreau-gaudry@u-bordeaux.fr.; Bedel A; Univ Bordeaux, INSERM, UMR 1312, BRIC (Bordeaux Institute of Oncology), Bordeaux, France. aurelie.bedel@u-bordeaux.fr.; CHU de Bordeaux, Biochemistry Laboratory, Bordeaux, France. aurelie.bedel@u-bordeaux.fr.
Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Academic Journal
Pistilli B; Department of Medical Oncology, Gustave Roussy, Villejuif, France. barbara.pistilli@gustaveroussy.fr.; INSERM 1279, Gustave Roussy, Villejuif, France. barbara.pistilli@gustaveroussy.fr.; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France. barbara.pistilli@gustaveroussy.fr.; Mosele F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Corcos N; INSERM 1279, Gustave Roussy, Villejuif, France.; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; Pierotti L; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat INSERM U1018, Université Paris-Saclay, Ligue Contre le Cancer, Villejuif, France.; Pradat Y; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Le Bescond L; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; CentraleSupélec, Inria, Université Paris-Saclay, Gif-Sur-Yvette, France.; Lacroix-Triki M; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; Department of Pathology, Gustave Roussy, Villejuif, France.; Nachabeh G; Projects and Promotion Division, Gustave Roussy, Villejuif, France.; Alfaro A; UMS AMMICa, CNRS UAR 3655, INSERM US23, Gustave Roussy, Villejuif, France.; Catelain C; UMS AMMICa, CNRS UAR 3655, INSERM US23, Gustave Roussy, Villejuif, France.; Job B; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Mami-Chouaib F; UMR1186, Gustave Roussy, Villejuif, France.; Badel S; UMR1186, Gustave Roussy, Villejuif, France.; Farace F; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Gustave Roussy, Université Paris-Saclay, 'Rare Circulating Cells' Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.; Oulhen M; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Gustave Roussy, Université Paris-Saclay, 'Rare Circulating Cells' Translational Platform, CNRS UMS3655 - INSERM US23 AMMICA, Villejuif, France.; Kannouche P; UMR9019-CNRS, Université Paris-Saclay, Gustave Roussy, Villejuif, France.; Tran DTN; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Droin N; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; UMS AMMICa, CNRS UAR 3655, INSERM US23, Gustave Roussy, Villejuif, France.; Vicier C; Department of Medical Oncology, Institut Paoli Calmettes, Marseille, France.; Frenel JS; Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Saint Herblain, France.; Nantes Université, INSERM, Centre de Recherche en Cancérologie et Immunologie Nantes Angers, Nantes, France.; D'Hondt V; Department of Medical Oncology, Institut Régional du Cancer de Montpellier, Montpellier, France.; Dalenc F; Department of Medical Oncology, Oncopole Claudius Regaud, Toulouse, France.; Bachelot T; Department of Medical Oncology, Centre Léon Bérard, Lyon, France.; Ducoulombier A; Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France.; Benderra MA; Department of Medical Oncology, Tenon Hospital, APHP, Paris, France.; Loirat D; Department of Medical Oncology, Curie Hospital, Paris, France.; Mayeur D; Department of Medical Oncology, Centre Georges François Leclerc, Dijon, France.; Deluche E; Department of Medical Oncology, Centre Hopital-Universitaire, Limoges, France.; Deneuve J; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; Cheikh-Hussin R; INSERM 1279, Gustave Roussy, Villejuif, France.; Guyader P; Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat INSERM U1018, Université Paris-Saclay, Ligue Contre le Cancer, Villejuif, France.; Signolle N; Department of Pathology, Gustave Roussy, Villejuif, France.; Godefroy K; Department of Pathology, Gustave Roussy, Villejuif, France.; Talbot H; CentraleSupélec, Inria, Université Paris-Saclay, Gif-Sur-Yvette, France.; Vakalopoulou M; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; CentraleSupélec, Inria, Université Paris-Saclay, Gif-Sur-Yvette, France.; Christodoulidis S; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; CentraleSupélec, Université Paris-Saclay, Gif-Sur-Yvette, France.; Bernard E; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Koudou Y; Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat INSERM U1018, Université Paris-Saclay, Ligue Contre le Cancer, Villejuif, France.; Sporchia A; Daiichi Sankyo Inc., Basking Ridge, NJ, USA.; Suto F; Daiichi Sankyo Inc., Basking Ridge, NJ, USA.; Li L; Daiichi Sankyo Inc., Basking Ridge, NJ, USA.; Sternberg DW; Daiichi Sankyo Inc., Basking Ridge, NJ, USA.; Michiels S; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; Office of Biostatistics and Epidemiology, Gustave Roussy, Oncostat INSERM U1018, Université Paris-Saclay, Ligue Contre le Cancer, Villejuif, France.; André F; Department of Medical Oncology, Gustave Roussy, Villejuif, France.; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; INSERM U981, Gustave Roussy, Paris, France.; Sellami D; Daiichi Sankyo Inc., Basking Ridge, NJ, USA.; Montagnac G; INSERM 1279, Gustave Roussy, Villejuif, France.; IHU PRISM National PRecISion Medicine Center in Oncology, Gustave Roussy, Villejuif, France.
Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Academic Journal
Fandrei D; INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Pegliasco J; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Pasquier F; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Ibrahim N; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Kfoury M; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Berthon C; Hematology Department, CHRU Lille, Lille, France.; Heiblig M; Hematology Department, Hôpital Lyon Sud, Vourles, France.; Lebon D; Hematology Department, CHU Amiens, Amiens, France.; Marçais A; Hôpital Necker, AP-HP, Paris, France.; Meunier M; Clinique Universitaire d'hématologie, CHU de Grenoble, Grenoble, France.; Al Jijakli A; CH Argenteuil, Argenteuil, France.; Lemasle E; Hematology Department, Centre Henri Becquerel, Rouen, France.; Chantepie S; Institut d'Hématologie, CHU de Caen, Caen, France.; Pautas C; Hematology Department, AP-HP, Hôpital Henri Mondor, Créteil, France.; Dumas PY; CHU Bordeaux, Service d'Hématologie Clinique et de Thérapie Cellulaire, Bordeaux, France.; BRIC UMR1312, INSERM, Université de Bordeaux, Bordeaux, France.; Salanoubat C; Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France.; Carp D; Centre Hospitalier d'Orléans, Orléans, France.; Loyaux R; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Quivoron C; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Pages A; Department of Biostatistics, Gustave Roussy, Villejuif, France.; Job B; Bioinformatics Platform, Gustave Roussy, Villejuif, France.; Jelin R; Bioinformatics Platform, Gustave Roussy, Villejuif, France.; Jules-Clement G; Bioinformatics Platform, Gustave Roussy, Villejuif, France.; Antony-Debré I; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Renneville A; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Cotteret S; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Itzykson R; Hôpital Saint-Louis, AP-HP, Paris, France.; Dombret H; Hôpital Saint-Louis, AP-HP, Paris, France.; Duployez N; Laboratory of Hematology, Centre Hospitalier Universitaire (CHU) Lille, Lille, France.; Droin N; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Leary A; INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Oncology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Marzac C; Department of Medical Biology and Pathology, Gustave Roussy, Villejuif, France.; Bernard E; INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; IHU PRISM National Precision Medicine Center in Oncology, Gustave Roussy, Villejuif, France.; Micol JB; INSERM U1287, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Department of Hematology, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Interception Program, Personalized Cancer Prevention Center, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[검색어] Droin N
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어